Vulnerability · CVE-2025-27937
Quick Agent V3 and Quick Agent V2 contain an issue with improper limitation of a pathname to a restricted directory ('Path Traversal').
Published Apr 27, 2025 · catalog updated Apr 28, 2025 · SIOS Technology, Inc. Quick Agent V2
Check this week
CVE-2025-27937 is not in CISA KEV. FIRST estimates a 69.00% chance of exploitation in the next 30 days. Check whether you run SIOS Technology, Inc. Quick Agent V2.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High7.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 69.00%
- Remediation
- Vendor / distro source
- Affected products
- vendor SIOS Technology, Inc. Quick Agent V2 prior to Ver2.9.8
Quick Agent V3 and Quick Agent V2 contain an issue with improper limitation of a pathname to a restricted directory ('Path Traversal'). If exploited, an arbitrary file in the affected product may be obtained by a remote attacker who can log in to the product.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor SIOS Technology, Inc. Quick Agent V2 prior to Ver2.9.8prior to Ver2.9.8
How to fix CVE-2025-27937
Recommended remediation
A vendor or distribution source is linked. Check that advisory for patch availability; this catalog does not invent fix status.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2025-27937 is not in CISA KEV. FIRST estimates a 69.00% chance of exploitation in the next 30 days. Check whether you run SIOS Technology, Inc. Quick Agent V2.
Which versions are affected?
Compare what you have installed with SIOS Technology, Inc. Quick Agent V2 prior to Ver2.9.8 prior to Ver2.9.8. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 69.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Apr 27, 2025 · EUVD
Detected
Quick Agent V3 and Quick Agent V2 contain an issue with improper limitation of a pathname to a restricted directory ('Path Traversal'). If exploited, an arbitrary file in the affected product may be obtained by a remote attacker who can log in to the product.
Apr 28, 2025 · EUVD
Updated
Quick Agent V3 and Quick Agent V2 contain an issue with improper limitation of a pathname to a restricted directory ('Path Traversal'). If exploited, an arbitrary file in the affected product may be obtained by a remote attacker who can log in to the product.
Sources
- CVE.orgVulnerability recordCVE-2025-27937
Official CVE identifier
cve.org - EUVDVulnerability recordEUVD-2025-12416
Quick Agent V3 and Quick Agent V2 contain an issue with improper limitation of a pathname to a restricted directory ('Path Traversal'). If exploited, an arbitrary file in the affected product may be obtained by a remote attacker who can log in to the product.
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.